Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus
- 31 January 1992
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 15 (1) , 89-96
- https://doi.org/10.1016/0168-8227(92)90073-z
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 8 references indexed in Scilit:
- Release of Amylin From Perfused Rat Pancreas in Response to Glucose, Arginine, β-Hydroxybutyrate, and GliclazideDiabetes, 1991
- Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1991
- Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment.Journal of Clinical Investigation, 1990
- Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogsDiabetologia, 1990
- Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in manDiabetologia, 1990
- ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETESThe Lancet, 1987
- A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreasBiochemical and Biophysical Research Communications, 1986
- Monolayer Cell Culture of Neonatal Rat Pancreas: Light Microscopy and Evidence for Immunoreactive Insulin Synthesis and ReleaseEndocrinology, 1972